We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience. I accept. Individual Privacy Preferences. Cookie Details Privacy Policy Imprint. Here you will find an overview of all cookies used. You can give your consent to whole categories or display further information and select certain cookies.
Accept all Save. Essential cookies enable basic functions and are necessary for the proper function of the website. Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website. Marketing cookies are used by third-party advertisers or publishers to display personalized ads. They do this by tracking visitors across websites.
Content from video platforms and social media platforms is blocked by default. If External Media cookies are accepted, access to those contents no longer requires manual consent. Privacy Policy Imprint. From Europe. For the global patent community. Pharmaceuticals Second Medical Use. Invention on dosage On Wednesday morning, Bayer and the 15 opponents came to the heart of the dispute. Natalie Kirchhofer. Receive the latest patent news direct to your inbox.
Related Articles Prescription for the future The pharmaceutical industry is in upheaval — as are its IP departments. Privacy Preference. Privacy Preference Here you will find an overview of all cookies used. Essential 2. Statistics 1. Marketing 1. Bayer has agreed to acquire the consumer care business of U. Modern wound management can shorten treatment and turn in-patient treatment into out-patient care, reducing time and costs.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences. I'm interested in more information … Read all latest stories. Bayer in cancer collaboration Finnish pharma company Orion and German healthcare giant Bayer have entered into an agreement for the development and commercialisation of a novel drug targeting prostate cancer.
0コメント